Comments on: New Diabetes Meds Must Have Heart Risk Info http://www.pharmalot.com/2008/12/new-diabetes-meds-must-have-heart-risk-info/ News, Comment and Conversation Fri, 10 Feb 2012 20:36:08 +0000 http://wordpress.org/?v=2.6.2 By: cheap diabetic testing supplies http://www.pharmalot.com/2008/12/new-diabetes-meds-must-have-heart-risk-info/#comment-403831 cheap diabetic testing supplies Tue, 21 Apr 2009 09:57:54 +0000 http://www.pharmalot.com/?p=18721#comment-403831 These latest recommendations are unlikely to go down well with the pharmaceutical firms who are developing new treatments for diabetes as they would inevitably led to more studies and increased costs. These latest recommendations are unlikely to go down well with the pharmaceutical firms who are developing new treatments for diabetes as they would inevitably led to more studies and increased costs.

]]> By: Salmon http://www.pharmalot.com/2008/12/new-diabetes-meds-must-have-heart-risk-info/#comment-385447 Salmon Tue, 23 Dec 2008 16:15:49 +0000 http://www.pharmalot.com/?p=18721#comment-385447 Ed, Your article states per the FDA that "Patients with diabetes have a 2 to 4 times greater risk of heart disease, and none of the currently approved antidiabetic therapies has been convincingly proven to reduce that risk, the FDA says in its statement." Except that the FDA says that Avandia increases the risk of cardiovascular toxicity 3 fold when added to insulin. The complete statement can be found on page 286 of the medical review approving the supplemental indication of Avandia in addition to insulin which is a publicly available document available on the Drugs@FDA.gov website. Salmon Ed,

Your article states per the FDA that

“Patients with diabetes have a 2 to 4 times greater risk of heart disease, and none of the currently approved antidiabetic therapies has been convincingly proven to reduce that risk, the FDA says in its statement.”

Except that the FDA says that Avandia increases the risk of cardiovascular toxicity 3 fold when added to insulin. The complete statement can be found on page 286 of the medical review approving the supplemental indication of Avandia in addition to insulin which is a publicly available document available on the Drugs@FDA.gov website.

Salmon

]]>